Medicamen Organics Ltd

NSE: MEDIORG

₹25.65

0.00 (0.00%)

As on 01-Sep-2026 15:17IST

Market cap

info icon

₹38 Cr

Revenue (TTM)

info icon

₹38 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.9

Div. Yield

info icon

0 %

Medicamen Organics Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 0.00 High: 0.00

52 Week Range

Low: 0.00 High: 38.00

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹4 Cr

  • ROEROE information

    18.1 %

  • ROCEROCE information

    17 %

  • Industry P/EIndustry P/E information

    39.17

  • EV/EBITDAEV/EBITDA information

    -12.6

  • Debt to EquityDebt to Equity information

    0.4

  • Book ValueBook Value information

    ₹25.1

  • EPSEPS information

    ₹3.5

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    14,880,195

5 Years Aggregate

CFO

₹-9.92 Cr

EBITDA

₹16.05 Cr

Net Profit

₹8.04 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Medicamen Organics
6.9 -5.5 6.9 -29.6 -- -- --
BSE Healthcare
18.1 1.0 9.6 17.6 22.5 14.1 12.2
As on 01-Sep-2026
Company
2025
Medicamen Organics
-55.1
BSE Small Cap
-6.6
BSE Healthcare
-3.3

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Medicamen Organics
25.7 38.2 38.2 4.1 -- 18.1 -- 0.9
1,443.7 17,722.7 2,590.4 603.0 29.3 19.6 29.4 5.1
586.4 11,119.0 885.7 234.9 27.8 18 47.3 5.0
1,484.3 15,517.7 1,108.4 270.2 28.3 14.5 56.4 7.5
1,845.9 35,014.7 9,683.5 1,019.0 15.7 21.3 34.6 6.7
23,025.0 29,554.9 2,371.8 497.8 28.0 28.5 59.4 14.6
947.9 5,661.6 942.6 9.9 0.3 1.2 653.3 4.4
1,454.7 6,694.1 691.7 130.8 24.5 14.5 53 6.9
1,230.9 13,821.5 675.6 183.6 32.2 22.7 75.7 15.0
381.6 10,762.8 8.8 -352.4 -4,228.0 -80.8 -- 19.3

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Medicamen Organics

--

  • Incorporated

    1995

  • Chairman

    --

  • Managing Director

    Bal Kishan Gupta

  • Headquarters

    New Delhi, Delhi

  • Website

    www.medicamenorganics.com

FAQs for Medicamen Organics

The share price of Medicamen Organics Ltd is ₹25.65 (NSE) as of 01-Sep-2026 15:17 IST. Medicamen Organics Ltd has given a return of -29.63% in the last 1 years.

Since, TTM earnings of Medicamen Organics Ltd is negative, P/E ratio is not available.
The P/B ratio of Medicamen Organics Ltd is 0.91 times as on 31-Aug-2026, a 75 discount to its peers’ median range of 3.61 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
6.27
0.86
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00
2021
0.00
0.00

The 52-week high and low of Medicamen Organics Ltd are Rs 38.00 and Rs 0.00 as of 02-Sep-2026.

Medicamen Organics Ltd has a market capitalisation of ₹ 38 Cr as on 31-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Medicamen Organics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...
loading...
loading...